Cargando…
A Small Compound Targeting Prohibitin with Potential Interest for Cognitive Deficit Rescue in Aging mice and Tau Pathology Treatment
Neurodegenerative diseases, including Alzheimer’s and Parkinson’s disease, are characterized by increased protein aggregation in the brain, progressive neuronal loss, increased inflammation, and neurogenesis impairment. We analyzed the effects of a new purine derivative drug, PDD005, in attenuating...
Autores principales: | Guyot, Anne-Cécile, Leuxe, Charlotte, Disdier, Clémence, Oumata, Nassima, Costa, Narciso, Roux, Gwenaëlle Le, Fernandez-Varela, Paloma, Duchon, Arnaud, Charbonnier, Jean Baptiste, Herault, Yann, Pavoni, Serena, Galons, Hervé, Andriambeloson, Emile, Wagner, Stéphanie, Meijer, Laurent, Lund, Amie K., Mabondzo, Aloïse |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981120/ https://www.ncbi.nlm.nih.gov/pubmed/31980673 http://dx.doi.org/10.1038/s41598-020-57560-3 |
Ejemplares similares
-
Author Correction: A Small Compound Targeting Prohibitin with Potential Interest for Cognitive Deficit Rescue in Aging mice and Tau Pathology Treatment
por: Guyot, Anne-Cécile, et al.
Publicado: (2020) -
Antitumoral effects of cyclin-dependent kinases inhibitors CR8 and MR4 on chronic myeloid leukemia cell lines
por: Troadec, Samuel, et al.
Publicado: (2015) -
Tissue biodistribution of intravenously administrated titanium dioxide nanoparticles revealed blood-brain barrier clearance and brain inflammation in rat
por: Disdier, Clémence, et al.
Publicado: (2015) -
A Simple Isomerization of the Purine Scaffold of a
Kinase Inhibitor, Roscovitine, Affords a Four- to Seven-Fold Enhancement
of Its Affinity for Four CDKs. Could This Be Traced Back to Conjugation-Induced
Stiffenings/Loosenings of Rotational Barriers?
por: El Hage, Krystel, et al.
Publicado: (2017) -
Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier Model
por: Roux, Gwenaëlle Le, et al.
Publicado: (2019)